Filter by
Filter by
Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.
Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Spot-Scanning Proton Arc SPArcTherapy - the first robust and delivery-efficient spot-scanning proton arc therapy
First publication on a variable energy proton Arc method: a robust and delivery-efficient spot-scanning proton arc therapy technique (aka SPArc). The aim was to...